Shares of Verici Dx plc (LON:VRCI – Get Free Report) traded up 14% during trading on Friday . The stock traded as high as GBX 2.93 ($0.04) and last traded at GBX 2.85 ($0.04). 1,706,122 shares were traded during trading, an increase of 75% from the average session volume of 975,578 shares. The stock had previously closed at GBX 2.50 ($0.03).
Verici Dx Stock Performance
The company has a quick ratio of 8.49, a current ratio of 4.54 and a debt-to-equity ratio of 4.64. The company has a fifty day moving average price of GBX 3.20 and a 200 day moving average price of GBX 3.89. The stock has a market cap of £8.73 million, a PE ratio of -1.67 and a beta of 1.59.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Stories
- Five stocks we like better than Verici Dx
- The Most Important Warren Buffett Stock for Investors: His Own
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- What Makes a Stock a Good Dividend Stock?
- Top 3 Beverage Stocks Pouring Out Profits
- Expert Stock Trading Psychology Tips
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
